tbuckley/cabot-search huggingface dataset:
Enabling the Implementation of Next-Generation Sequencing into Clinical Diagnosis: Nemhesys Project
Authors: Jesús María Hernández-Rivas, Inmaculada Serramito-Gómez, Saara Kallio, Amparo Cantalejo, Jana Kotaskova, Ana E. Rodriguez, María Abáigar, Rocio Benito, Anna Dolnik, Mark Catherwood, Jaine Blayney, Boris Tichý, Ivana Chalupová, Philippe Dubois, Roberto Lopez, Carlos Barranquero, María Díaz Lorenzo, Mylène Leitzelman, Sadiksha Adhikari, Šárka Pospíšilová, Lars Bullinger, Ken I Mills, Caroline A. Heckman
Journal: Blood (2022)
Combining Plasma Cell Leukemia-like Status with the Second Revision of the International Staging System Improves Risk Classification
Authors: Davine Hofste op Bruinink, Rowan Kuiper, Mark van Duin, Tom Cupedo, Vincent H.J. van der Velden, Remco Hoogenboezem, Bronno van der Holt, Berna Beverloo, Erik T. Valent, Michael Vermeulen, Mattia D'Agostino, Francesca Gay, Annemiek Broijl, Herve Avet-Loiseau, Nikhil C Munshi, Pellegrino Musto, Philippe Moreau, Sonja Zweegman, Niels W.C.J. van de Donk, Pieter Sonneveld
Journal: Blood (2022)
Dose-Intense Frontline Chemotherapy Changes Molecular Classifier Prognostication in Diffuse Large B-Cell Lymphoma(DLBCL)
Authors: Tatyana Feldman, Maher Albitar, Hong Cheng, Kar Chow, Alessandra Petrillo, Ahmetmursel Ulusan, Andrew Ip, Alexandra Della Pia, Gabriella Magarelli, Brittany Lukasik, Lori Leslie, Pritish K. Bhattacharyya, Andrew L. Pecora, Andre H. Goy
Journal: Blood (2022)
Overall and Subgroup Results from the Third Interim Analysis of FIRE, a Real-World Study of Ibrutinib Treatment for CLL/SLL in France
Authors: Caroline Dartigeas, Loic Ysebaert, Pierre Feugier, Alain Delmer, Sandrine Dupuis, Marine Deslandes, Marjolein Lahaye, Veronique Leblond
Journal: Blood (2022)
Clinical Activity of Anti-PD-1 Therapy Following CD30 CAR-T Cell Therapy in Relapsed Hodgkin Lymphoma
Authors: Timothy J. Voorhees, Anne W. Beaven, Christopher Dittus, George E Hucks, J. Kaitlin Morrison, Catherine Joyce Arago Cheng, Tammy Cavallo, Steven I. Park, Gianpietro Dotti, Jonathan S. Serody, Barbara Savoldo, Natalie S. Grover
Journal: Blood (2022)
Cognitive Dysfunction Worsens with Age in Patients with Sickle Cell Disease in the Modern Treatment Era
Authors: Landon C. Power, Michael M. Binkley, Kristin P. Guilliams, Jade Beshears, Amal Hamed, Anna M Hood, Jin-Moo Lee, Andria L. Ford, Allison A. King, Melanie E. Fields
Journal: Blood (2022)
Transcriptional and Metabolic Profiling Reveals Alpha-Ketoglutarate As a Novel Mediator of Aberrant Platelet Activity and Inflammation in Myeloproliferative Neoplasms
Authors: Fan He, Angelo BA Laranjeira, Tim Kong, Katrina Bark, Alice Liu, Maggie J. Allen, Daniel AC Fisher, Mary Fulbright, LaYow Yu, Nina M. Lasky, Stephen M. Sykes, Angelo D'Alessandro, Jorge Di Paola, Stephen T Oh
Journal: Blood (2022)
High Preponderance of High-Risk Phenotypes of Acute Leukemias Among Ugandan Children
Authors: Ruth Namazzi, Peter Wasswa, Amos S. Gaikwad, Hellen Mugarura, Micheal Cubbage, Moreen Nanvuma, Betty Najjukko, Fred Lutwama, David G. Poplack, Michael E. Scheurer, Joseph Lubega
Journal: Blood (2022)
Targeted Deletion of Activated T Cells with a Single Dose of Anti-CD137-Antibody Drug Conjugate Protects Against Acute Gvhd (AGVHD) and Promotes Tolerogenic T Cell Reconstitution after Haplo-Identical Hematopoietic Stem Cell Transplantation (HSCT)
Authors: Ulrike Gerdemann, Jennifer Lane, Kyle Kimler, Leanne Lanieri, Lisa Olson, Leslie S. Kean, Victor Tkachev
Journal: Blood (2022)
Late Morbidity and Mortality after Autologous Blood or Marrow Transplantation (BMT) for Lymphoma in Children, Adolescents and Young Adults - a Report from the BMT Survivor Study (BMTSS)
Authors: Anna Sallfors Holmqvist, Qingrui Meng, Chen Dai, Lindsey Hageman, Wendy Landier, Jessica Wu, Liton F. Francisco, Elizabeth Schlichting, Nora Balas, Alysia Bosworth, Hok Sreng Te, Ravi Bhatia, Joseph Rosenthal, Lennie Wong, Daniel J. Weisdorf, Saro H. Armenian, Smita Bhatia
Journal: Blood (2022)
RAS Mutations in Adult Acute Myeloid Leukemia (AML). Frequency, Mutational Spectrum, and Identification of a Comutation Bias for <i>KRAS</i>K117 (<i>TET2</i>/<i>ASXL1</i>)
Authors: Alícia Artigas-Baleri, Helena Castellet, Marta Pratcorona, Lurdes Zamora, Monica Lopez-Guerra, Bárbara Tazón, Susana Vives, Mar Tormo, Montserrat Arnan, Antoni Garcia-Guiñon, Rosa Coll., Antonia Sampol, Joan Bargay, Ferran Vall-Llovera, Olga Salamero, Felix Lopez-Cadenas, Ana Garrido Díaz, Jordi Esteve, Jorge Sierra, Josep F Nomdedeu
Journal: Blood (2022)
Comedication of Proton Pump Inhibitors and Dasatinib Is Common in CML but XS004, a Novel Amorphous Solid Dispersion Formulation of Dasatinib, Provides Improved Uptake and Low pH-Dependency, Minimizing Unwanted Drug-Drug Interactions
Authors: Gunnar Larfors, Hans Lennernäs, Charlotta Liljebris, Magnus Brisander, Gérald Jesson, Per Andersson, Leif Stenke
Journal: Blood (2022)
Prognostic Model of Transformation to Blast Phase in Patients with Chronic Myeloid Leukemia
Authors: Alex Bataller, Koji Sasaki, Elias Jabbour, Ghayas C. Issa, Fadi Haddad, Jeffrey Skinner, Sara E Dellasala, Guillermo Garcia-Manero, Sherry A. Pierce, Hagop Kantarjian
Journal: Blood (2022)
Costimulatory Domains Direct Distinct Fates of CAR T Cell Dysfunction
Authors: Mehmet Emrah Selli, Jack Landmann, John Lattin, Amanda Heard, John Warrington, Helen Ha, Jufang Chang, Natalie Kingston, Graham Hogg, Mark Foster, Samantha Kersting-Schadek, Marina Terekhova, David DeNardo, Todd A. Fehniger, Maxim Artyomov, Nathan Singh
Journal: Blood (2022)
IPSS-Molecular but Not Individual Mutations Predicts Outcomes of Patients with Myelodysplastic Syndrome (MDS) after Allogeneic Hematopoietic Cell Transplantation (Allo-HCT): A Mayo Clinic Cohort
Authors: Razan Mohty, Yenny Moreno Vanegas, Michael G. Heckman, Hassan B. Alkhateeb, Alexander P. Hochwald, William J. Hogan, Mohamed A. Kharfan-Dabaja, Rhett P. Ketterling, Nandita Khera, Mark R. Litzow, Abhishek A. Mangaonkar, Hemant S. Murthy, Jeanne M. Palmer, Mithun V. Shah, Lisa Z. Sproat, David S. Viswanatha, James M. Foran
Journal: Blood (2022)
Energy Trial in Warm Autoimmune Hemolytic Anemia (wAIHA): Design of a Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Nipocalimab, an FcRn Blocker
Authors: Irina Murakhovskaya, Bruno Fattizzo, Tarek Ebrahim, Kristen Sweet, Cathye Shu
Journal: Blood (2022)
Interim Results of the Phase 1 Study of Tnb-486, a Novel CD19xCD3 T-Cell Engager, in Patients with Relapsed/Refractory (R/R) B-NHL
Authors: Jing-Zhou Hou, Ryan Jacobs, Seok-Goo Cho, Sumana Devata, Sameh Gaballa, Dok Hyun Yoon, Don A. Stevens, Jin Seok Kim, Ben Buelow, Ranjit Nair
Journal: Blood (2022)
Frontline PET-Directed Therapy with Brentuximab Vedotin Plus AVD Followed By Nivolumab Consolidation in Patients with Limited Stage Hodgkin Lymphoma
Authors: Steven I. Park, Stephen M. Ansell, Sharmila Giri, Jakub Svoboda, Stephen D Smith, Tatyana Feldman, Elizabeth L. Budde, Andrew J Ness, Yunsik Choi, Philip J Bierman, Hun Ju Lee
Journal: Blood (2022)
Fixed Duration Therapy with Daratumumab, Carfilzomib, Lenalidomide and Dexamethasone for High Risk Smoldering Multiple Myeloma-Results of the Ascent Trial
Authors: Shaji K Kumar, Melissa Alsina, Betsy Laplant, Ashraf Z. Badros, Al-Ola Abdallah, Rafat Abonour, Erik J Asmus, Binod Dhakal, Cara A. Rosenbaum, Daniel Egan, Manisha Bhutani, Andrzej Jakubowiak, Brian G.M. Durie
Journal: Blood (2022)
AML MRD By Multiparameter Flow Cytometry Using Laip/Dfn and LSC: Methodological Aspects in a Multicentric Study of the French-Flow MRD AML ALFA Network
Authors: Adriana Plesa, Florent Dumezy, Stéphanie Mathis, Anne-Catherine Lhoumeau, Valerie Bardet, Véronique Saada, Isabelle Arnoux, Bouchra Badaoui, Edouard Cornet, Jennifer Osman, Estelle Guerin, Nicolas Chapuis, Franck Genevieve, Rémi Letestu, Delphine Manzoni, Anne Roggy, Mikael Roussel, Véronique Harrivel, Elsa Bera, Caroline Mayeur-Rousse, Hélène Lapillonne, Richard Veyrat-Masson, Lydia Campos, Magali Le Garff-Tavernier, Tatiana Raskovalova, Francois Vergez, Julien Guy, Agnes Charpentier, Claire Hemar, Valerie Goncalves Monteiro, Frederic Fegier, Karine Celli-Lebras, Raphael Itzykson, Herve Dombret, Claude Preudhomme, Christophe Roumier
Journal: Blood (2022)
Permanent Discontinuation of Tyrosine Kinase Inhibitor Frontline Therapy in Patients with Chronic Phase Chronic Myeloid Leukemia Patients during the First 36 Months of Treatment: A "Campus CML" Study
Authors: Roberto Latagliata, Isabella Capodanno, Maria Cristina Miggiano, Alessandra Iurlo, Francesco Cavazzini, Sabrina Leonetti Crescenzi, Sabina Russo, Ida Carmosino, Andrea Bernardelli, Olga Mulas, Chiara Elena, Gianni Binotto, Elena Crisà, Ambra Di Veroli, Anna Rita Scortechini, Maria Basile, Monica Crugnola, Pamela Murgano, Michele Pizzuti, Cristina Bucelli, Carmen Fava, Matteo Dalmazzo, Francesca Lunghi, Giovanni Caocci, Massimiliano Bonifacio, Giuseppe Saglio, Giorgina Specchia, Massimo Breccia, Mario Tiribelli
Journal: Blood (2022)
ASC4FIRST: A Phase III Study of Asciminib vs Investigator-Selected Tyrosine Kinase Inhibitor in Patients with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP)
Authors: Timothy Hughes, Jorge E. Cortes, Naoto Takahashi, Richard A. Larson, Ghayas C. Issa, Felice Bombaci, Nicholas Ramscar, Shruti Kapoor, Sophie Ifrah, Andreas Hochhaus
Journal: Blood (2022)
Multiple Myeloma Evolution Is Characterized By Dynamic Epigenetic Landscapes
Authors: Rafael Renatino-Canevarolo, Mark B. Meads, Maria L. Coelho Siqueira Silva, Praneeth Reddy Sudalagunta, Christopher Cubitt, Gabriel De Avila, Raghunandan Reddy Alugubelli, Amit Kulkarni, Qi Zhang, Oliver Hampton, Rachid C. Baz, Kenneth H. Shain, Ariosto Siqueira Silva
Journal: Blood (2022)
An Unsupervised Machine Learning Method Stratifies Chronic Lymphocytic Leukemia Patients in Novel Categories with Different Risk of Early Treatment
Authors: Francesca Cuturello, Federico Pozzo, Edith Natalia Villegas Garcia, Francesca Maria Rossi, Massimo Degan, Paola Nanni, Ilaria Cattarossi, Eva Zaina, Paola Varaschin, Alessandra Braida, Michele Berton, Laura Zannier, Filippo Vit, Erika Tissino, Tamara Bittolo, Roberta Laureana, Giovanni D'Arena, Luca Laurenti, Agostino Tafuri, Jacopo Olivieri, Francesco Zaja, Annalisa Chiarenza, Maria Ilaria Del Principe, Riccardo Bomben, Antonella Zucchetto, Stefano Cozzini, Alessio Ansuini, Alberto Cazzaniga, Valter Gattei
Journal: Blood (2022)
Comparative Effectiveness of Lisocabtagene Maraleucel (Liso-cel) in PILOT in Patients (Pt) with Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL) for Whom Transplant Was Not Intended (TNI) Versus Conventional Second-Line (2L) Chemotherapy Regimens in the Real World
Authors: Nilanjan Ghosh, Alison R. Sehgal, Fei Fei Liu, Ana Kostic, Alessandro Crotta, Lily Peng, Marc De Benedetti, Leo I. Gordon
Journal: Blood (2022)
Efficacy and Safety of Treatment Venetoclax Monotherapy or Combined with Rituximab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) in the Real-World Setting in Spain: An Update of the Venares Study
Authors: Christelle Ferra, María José Terol, Juan Marquet Palomanes, Angel Ramírez Payer, Carol Moreno, Santiago Osorio, Fátima De la Cruz, Jose A. Garcia-Marco, Macarena Ortiz, Eduardo Rios Herranz, Laura Magnano, Sandra Iraheta, Jose Manuel Puerta, Javier de la Serna, Alicia Smucler, Jose Maria Arguiñano, Javier Loscertales, Begoña Muiña, Rubén Fernández, Tomas García, José A. Márquez, Ana Muntañola Prat, Ernesto Perez Persona, Lucrecia Yáñez, Manuel Pérez-Encinas, Marcos González Díaz, Gonzalo Caballero, María Angeles Andreu, Rafael Andreu, Ana Ruiz-Zorrilla, Diana Moreno, Patricia Baltasar
Journal: Blood (2022)
Risk of Immune Thrombocytopenia Relapse and Onset Related to Sars-Cov-2 Infection and Vaccination
Authors: Giuseppe Auteri, Camilla Mazzoni, Mattia Biondo, Simona Paglia, Marta Venturi, Andrea Davide Romagnoli, Daniela Bartoletti, Michele Cavo, Nicola Vianelli, Francesca Palandri
Journal: Blood (2022)
Allogeneic Hematopoietic Cell Transplantation in Patients with Therapy-Related Myeloid Neoplasm Following Treatment for Lymphoma: A Study of the Chronic Malignancies Working Party of the EBMT
Authors: Mitja Nabergoj, Dirk-Jan Eikema, Nienke Zinger, Uwe Platzbecker, Katja Sockel, Jürgen Finke, Nicolaus Kröger, Edouard Forcade, Arnon Nagler, Arnold Ganser, Johanna Tischer, Annoek E.C. Broers, Jurgen Kuball, Keith Wilson, Hunault-Berger Mathilde, Matthew P. Collin, Domenico Russo, Estefanía Pérez López, Grzegorz Helbig, Alberto Mussetti, Kavita Raj, Christof Scheid, Donal P. McLornan, Marie Robin, Ibrahim Yakoub-Agha
Journal: Blood (2022)
Patient-Reported Outcome Measures in Newly Diagnosed Acute Myeloid Leukemia: An Exploratory Analysis of Real-World Data
Authors: Xin Wang, Peter Gabriel, Abigail Doucette, Phyllis A. Gimotty, Kelly D. Getz, Samuel Takvorian, Alexander E. Perl, Shannon R. McCurdy, Selina M. Luger, Noelle V. Frey, Alison W. Loren, Elizabeth O. Hexner, Daria V. Babushok, David L. Porter, Keith W. Pratz, Catherine Lai
Journal: Blood (2022)
Healthcare Resource Utilization and Costs Associated with AL Amyloidosis: A Retrospective Matched Cohort Study
Authors: Hsin-An Hou, Shih-Pei Shen, Kuan-Chih Huang, Choo Hua Goh, Hong Qiu, Lee Anne Rothwell, Kwang-We Wu, Hitesh Chandwani, Yanfang Liu, Chao-Hsiun Tang
Journal: Blood (2022)
Therapeutic Modulation of the Marrow Microenvironment in MDS: A Phase I Trial of Abaloparatide and Bevacizumab
Authors: Jozal W. Moore, Jason H. Mendler, Kah Poh (melissa) Loh, Mitra Azadniv, Kristen M. O'Dwyer, Eric J. Huselton, Frank Akwaa, Benjamin J. Frisch, Myla Strawderman, Mark W. LaMere, Daniel K. Byun, Alyssa C. Jasper, Michael W. Becker, Jane L. Liesveld, Laura M. Calvi
Journal: Blood (2022)
Combination of a TGF-β Ligand Trap (RAP-GRL) and <i>TMPRSS6</i>-ASO Is Superior for Correcting β-Thalassemia
Authors: Amaliris Guerra, Perry Demsko, Ariel Rivera, Carlo Castruccio Castracani, Laura Breda, Naoto Tanaka, Shuling Guo, Stefano Rivella
Journal: Blood (2022)
Sex Hormone Levels, Biomarkers of Hypercoagulability and Endothelial Cell Activation Are Determinants of Severity of COVID-19 in Women and Men. the Roadmap-COVID-19 Prospective Study
Authors: Patrick Van Dreden, Salahdin Khelifi Otmane, Grigorios T. Gerotziafas, Matthieu Grusse, Aurélie Rousseau, Lila Louadj, Michele Sabbah
Journal: Blood (2022)
Similar Patient-Reported Quality of Life in the US and UK in Patients with Sickle Cell: A Comparative Grndad/Cousin Study
Authors: Sophie M. Lanzkron, Jane Alison Little, Daniel Semakula, Jessica Liang, Sara Stuart-Smith, Rachel Kesse-Adu, Julie Kanter, Alice J. Cohen, Sana Saif Ur Rehman, Stephanie H Guarino, Deepa Manwani, Payal C Desai, Kate Gardner
Journal: Blood (2022)
L-Mind: A Safety and Efficacy Analysis of Tafasitamab in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL) Receiving Treatment for at Least 2 Years
Authors: Johannes Duell, Wojciech Jurczak, Anna Marina Liberati, Janusz Halka, Esther Pena Carbó, Pau Abrisqueta Costa, Kami J. Maddocks, Martin Dreyling, Andreas Rosenwald, Abhishek Bakuli, Aasim Amin, Konstantin Gurbanov, Gilles Salles
Journal: Blood (2022)
A Clinical Laboratory-Oriented Targeted RNA-Seq System Accurately and Efficiently Detected Various Fusion Gene Mutations in Philadelphia Chromosome-like Acute Lymphoblastic Leukemia
Authors: Yong Jun Choi, Ju Heon Park, Young Eun Lee, Ha Jin Lim, Ji Hu Jeon, Hye Ran Kim, Jong Hee Shin, Myung-Geun Shin
Journal: Blood (2022)
Choice of Tyrosine Kinase Inhibitor and Early Events during the First Year of Therapy in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia (CML) Patients with Concomitant Diabetes: A "Campus CML" Study
Authors: Isabella Capodanno, Mario Tiribelli, Maria Cristina Miggiano, Cristina Bucelli, Francesco Cavazzini, Sabrina Leonetti Crescenzi, Sabina Russo, Emilia Scalzulli, Andrea Bernardelli, Luigiana Luciano, Olga Mulas, Giuseppina Loglisci, Chiara Elena, Umberto Pizzano, Immacolata Attolico, Gianni Binotto, Elena Crisà, Paolo Sportoletti, Ambra Di Veroli, Anna Rita Scortechini, Annapaola Leporace, Maria Basile, Monica Crugnola, Fabio Stagno, Pamela Murgano, Davide Rapezzi, Debora Luzi, Alessandra Iurlo, Monica Bocchia, Carmen Fava, Alessandra Malato, Sara Galimberti, Iolanda Donatella Vincelli, Malgorzata Monika Trawinska, Michele Pizzuti, Giovanni Caocci, Massimiliano Bonifacio, Giuseppe Saglio, Giorgina Specchia, Massimo Breccia, Roberto Latagliata
Journal: Blood (2022)
Orca-Q Demonstrates Favorable GvHD-and-Relapse-Free Survival in Haploidentical Transplants without Post-Transplant Cyclophosphamide
Authors: Amandeep Salhotra, Samer A Srour, Rasmus T Hoeg, Ayman Saad, Everett H Meyer, Anna Pavlova, Edmund K. Waller, Mwe Mwe Chao, J Scott McClellan, Nathaniel B Fernhoff, Robert Lowsky, Mehrdad Abedi
Journal: Blood (2022)
Orelabrutinib in Combination with Rituximab and Chemotherapy for Newly Diagnosed Aggressive B-Cell Lymphoma: A Multicenter, Single-Arm, Prospective Study
Authors: Xiangxiang Zhou, Xiaoqian Liu, Yurou Chu, Xiaoxia Chu, Jie Li, Haiyan Zhang, Changyong Yuan, Xiuzhi Deng, Guoqiang Liu, XianQi Feng, Wei Wang, Zhaogang Sun, Xiaosheng Fang, Mei Ding, Dai Yuan, Xueling Ge, Ying Li, Xin Liu, Lingyan Zhang, Xin Wang
Journal: Blood (2022)
Impact of Inotuzumb Ozogamicin on Outcome in Relapsed or Refractory Acute B-Lymphoblastic Leukemia Patients Prior to Allogeneic Hematopoietic Stem Cell Transplantation
Authors: Sabine Kayser, Chiara Sartor, Fabio Giglio, Alessandro Bruno, Jonathan Webster, Mark J. Levis, Richard F. Schlenk, Cristina Papayannidis
Journal: Blood (2022)
Enduring Responses after 1-Year, Fixed-Duration Cevostamab Therapy in Patients with Relapsed/Refractory Multiple Myeloma: Early Experience from a Phase I Study
Authors: Alexander M Lesokhin, Joshua Richter, Suzanne Trudel, Adam D Cohen, Andrew Spencer, Peter A Forsberg, Jacob P Laubach, Sheeba K Thomas, Nizar J. Bahlis, Luciano J. Costa, Paula Rodriguez Otero, Maria-Victoria Mateos, Jesus G Berdeja, Rayan Kaedbey, Amrita Y. Krishnan, Rafael Fonseca, Voleak Choeurng, James Cooper, Teiko Sumiyoshi, Chihunt Wong, Simon J Harrison
Journal: Blood (2022)
Treatment-Related Circulatory Diseases and Mortality in Hodgkin Lymphoma Patients Using Multi-State Modelling and Relative Survival
Authors: Joachim Baech, Lasse Hjort Jakobsen, Tarec Christoffer Christoffer El-Galaly, Daniel Molin, Ingrid Glimelius, Joshua P.P. Entrop, Michael Crowther, Karin Ekstroem Smedby, Sandra Eloranta, Caroline E. Weibull
Journal: Blood (2022)
Low-Dose Rhein Sensitizes Platelet Production to Thrombopoietin Receptor Agonists (TPO-RA) in Immune Thrombocytopenia
Authors: Lu Sun, Ruting Wang, Juan Wang, Yafei Yu, Haoyi Wang, Yitong Xu, Mingfang Zhu, Xin Wang, Yu Hou, Ming Hou
Journal: Blood (2022)
T-Cell Lymphocyte Kinetics As a Predictive Biomarker of Blinatumomab MRD Response in ALL-B Patients: A Single-Center Prospective Study
Authors: Uros Markovic, Andrea Duminuco, Nunziatina Laura Parrinello, Luca Lo Nigro, Elisa Mauro, Calogero Vetro, Marina Parisi, Cinzia Maugeri, Giuseppe Milone, Alessandra Romano, Francesco Di Raimondo, Salvatore Leotta
Journal: Blood (2022)
CNS Relapse in T-Cell Lymphoma Index: A Risk Score to Predict Central Nervous System Relapse in Patients with T-Cell Lymphomas
Authors: Rahul S. Bhansali, Fredrik Ellin, Miao Cao, Thomas Relander, Wenrui Li, Qi Long, Nivetha Ganesan, Robert Stuver, Steven M. Horwitz, Kitsada Wudhikarn, Steven R Hwang, N. Nora Bennani, Julio C. Chavez, Lubomir Sokol, Hayder Saeed, Frank Duan, Pierluigi Porcu, Priyanka Pullarkat, Neha Mehta-Shah, Jasmine Zain, Miguel Ruiz, Jonathan E Brammer, Rishab Prakash, Swami P. Iyer, Adam J. Olszewski, Ajay Major, Sonali M. Smith, Peter A. Riedell, Caroline Goldin, Bradley M. Haverkos, Bei Hu, Pamela B. Allen, Wael Toama, Murali Janakiram, Taylor Brooks, Deepa Jagadeesh, Nisha Hariharan, Aaron M Goodman, Paola Ghione, Fatima Fayyaz, Joanna M. Rhodes, Elise A. Chong, James N. Gerson, Daniel J. Landsburg, Sunita Dwivedy Nasta, Stephen J. Schuster, Jakub Svoboda, Mats Jerkeman, Stefan K. Barta
Journal: Blood (2022)
Improved Grfs Observed in a Multicenter Prospective Study of Tcrαβ- and CD45RA-Depleted Haploidentical Transplant in Children with Acute Leukemia
Authors: Chengjuan Luo, Shaoyan Hu, Xiaoqin Feng, Jun Lu, Hua Zhu, Yongsheng Ruan, Jing Ling, Changying Luo, Jianmin Wang, Yuanyuan Tian, Bohan Li, Wing H. Leung, Jing Chen
Journal: Blood (2022)
Improving Rates of Annual Transcranial Doppler Screening in Children with Sickle Cell Disease: A Quality Improvement Project
Authors: Jeffrey G Edwards, Adam P Yan, Ramy Yim, Eileen Hansbury, Matthew M. Heeney, Dave Johnson, Heather McMullan, Chris Wong Quiles, Maya Ilowite, Natasha M. Archer
Journal: Blood (2022)
Hosu-53, a Novel Potent Dihydroorotate Dehydrogenase Inhibitor Accentuates CD47 Blockade Therapy Resulting in Long Term Survival in Acute Myeloid Leukemia
Authors: Ola A Elgamal, Sandip Vibhute, Blaise Stearns, Susheela Tridandapani, Thomas E Goodwin, Gerard Hilinski, Chad Bennett, Jeffrey Patrick, Erin Hertlein, John C. Byrd
Journal: Blood (2022)
Lacutamab in Patients with Advanced Sezary Syndrome: Results from an Interim Analysis of the Tellomak Phase 2 Trial
Authors: Martine Bagot, Youn H. Kim, Pablo L. Ortiz-Romero, Pier Luigi Zinzani, Neha Mehta-Shah, Olivier Dereure, Marie Beylot-Barry, Stéphane Dalle, Eric D Jacobsen, Auris Huen, Andrea Combalia, Maxime Battistella, Alejandro A. Gru, Hélène Moins-Teisserenc, Michael S. Khodadoust, Julien Viotti, Christine Paiva, Marianna Muller, Pierluigi Porcu
Journal: Blood (2022)
Outcomes of Patients Treated with Low-Intensity Re-Induction Therapy for Persistent Disease after a Single Intensive Induction Cycle for Newly Diagnosed Acute Myeloid Leukemia (AML)
Authors: Sameem Abedin, Skyler Taylor, Guru Subramanian Guru Murthy, Lyndsey Runaas, Laura C. Michaelis, Karen-Sue Carlson, Ehab L. Atallah
Journal: Blood (2022)
ABVD for Hodgkin Lymphoma in Malawi; Excellent Outcomes but with Persistent Clinical Disparities Compared to High-Income Countries: A Prospective Cohort Study
Authors: Marriam Mponda, Evaristar Kudowa, Bongani Kaimila, Edwards Kasonkanji, Noel Mumba, Lusayo Simwinga, Tamiwe Tomoka, Yuri Fedoriw, Matthew Painschab
Journal: Blood (2022)
Eptacog Beta Efficacy in Treating Mild or Moderate Bleeds in Target Joints of Individuals with Hemophilia A or B and Inhibitors in PERSEPT 1
Authors: Mark T Reding, Maria Elisa Mancuso, Suchitra Acharya, Sanjay Ahuja, Maria Teresa Álvarez-Román, Lisa N Boggio, Meera B. Chitlur, Abraham Salvador Majluf-Cruz, Amy L Dunn, Miguel Escobar, Annie Harroche, Maissaa Janbain, Craig M. Kessler, Philip Maes, Catherine E. McGuinn, Danielle Nance, Ulrike Nowak-Göttl, Robert F. Sidonio, Jr., Duc Q Tran, Michael Wang, Jerzy Windyga, Hongying Wang, Thomas Wilkinson, Steven W. Pipe
Journal: Blood (2022)
Septic Shock and Septic Shock Mortality in Relation to Social Disorganization Index Among Children Being Treated for De Novo Acute Myeloid Leukemia on COG Clinical Trials
Authors: Jenny Ruiz, Yimei Li, Yuan-Shung V. Huang, Lusha Cao, Vicky Tam, Heather M. Griffis, Lena E. Winestone, Brian T. Fisher, Todd A. Alonzo, Anders E. Kolb, Karen Glanz, Kelly D. Getz, Richard Aplenc, Alix E. Seif
Journal: Blood (2022)
Molecular Response of ≤10% <i>BCR::ABL1IS</i> Is Predictive of Positive Outcomes in Treatment-Resistant Patients with Chronic Phase Chronic Myeloid Leukemia (CP-CML) Treated with Ponatinib from the Phase 2 Optic Trial
Authors: Jane F. Apperley, Jorge E. Cortes, Elias Jabbour, Andreas Hochhaus, Timothy Hughes, Charles Chuah, Hugues de Lavallade, Michael W. Deininger, Jeffrey H. Lipton, Elza Lomaia, Lori Maness, Michael Mauro, James McCloskey, Beatriz Moiraghi, Carolina Pavlovsky, Christine Rojas, Philippe Rousselot, Tomasz Sacha, Moshe Talpaz, Anna Turkina, Maria Undurraga Sutton, Xiaowei Ren, Alexander Vorog, Gianantonio Rosti
Journal: Blood (2022)
Combination of Mitoxantrone Hydrochloride Liposome with Cyclophosphamide, Vincristine and Prednisone (CMOP) in Treatment-Naïve Patients with Peripheral T-Cell Lymphoma: A Multicenter, Open-Label, Single-Arm, Phase Ib Clinical Trial
Authors: Hui-Qiang Huang, Gao Yan, Ming Jiang, Lihong Liu, Qing Xiao, Yufu Li, Hui Zhou, Jianfei Xue, Dong Wang, Dapeng Xie, Honglian Li, Peng Wang
Journal: Blood (2022)